SCHEMBL1455883

SCHEMBL1455883

O=C(O)N1CCOC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16416569 0.86 PIK3CD (0.41)
SCHEMBL7569177 0.82 NAAA (0.48)
SCHEMBL11449421 0.81 NAAA (0.44)
SCHEMBL11254970 0.78
SCHEMBL18832718 0.78
SCHEMBL3145817 0.78
SCHEMBL1027659 0.78
SCHEMBL11447863 0.75 NAAA (0.43)
SCHEMBL17747689 0.74 NAAA (0.60)
SCHEMBL11647947 0.73 CYP2C9 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0697408-B1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists MERCK PATENT GMBH (DE) 2002-01-23 EP claimed
US-5614535-A Adhesion receptor antagonists MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1997-03-25 US claimed
JP-8092227-A None JP disclosed
WO-2022234852-A1 PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND 中外製薬株式会社 2022-11-10 WO disclosed
CN-115298176-A Compounds and their use in the treatment of bacterial infections 豪夫迈·罗氏有限公司 2022-11-04 CN disclosed
US-9670237-B2 Phosphonium-based ionic liquids and their use in the capture of polluting gases UT-BATTELLE, LLC (US) 2017-06-06 US disclosed
US-20130078170-A1 PHOSPHONIUM-BASED IONIC LIQUIDS AND THEIR USE IN THE CAPTURE OF POLLUTING GASES UT BATTELLE (US) 2013-03-28 US disclosed
US-20120258960-A1 NOVEL MULTIFUNCTIONAL PEPTIDASE INHIBITORS, ESPECIALLY FOR MEDICAL USE IMTM GMBH (DE) 2012-10-11 US disclosed
WO-2011026781-A1 NOVEL MULTIFUNCTIONAL PEPTIDASE INHIBITORS, ESPECIALLY FOR MEDICAL USE IMTM GMBH (DE) 2011-03-10 WO disclosed
EP-2292589-A1 Novel multifunctional peptidase inhibitors, especially for medical use IMTM GmbH (DE) 2011-03-09 EP disclosed
CN-101356156-A Aspartic protease inhibitors VITAE PHARMACEUTICALS INC (US) 2009-01-28 CN disclosed
CN-1406576-A Oil in water low emulsifier or non-emulsifier system containing stabilizer and amiho substituted hydroxy diphenyl ketone BASF AG (DE) 2003-04-02 CN disclosed
CN-1406577-A Cosmetic W/O emulsion and agents for skin containing amino substituted hydroxy diphenyl ketone BASF AG (DE) 2003-04-02 CN disclosed
WO-2002045853-A1 LEWIS ACID CATALYSIS USING CHIRAL METAL COMPLEXES DOYLE MICHAEL P (US) 2002-06-13 WO disclosed
US-6319932-B1 USEFUL FOR TREATING BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2001-11-20 US disclosed
WO-2000027827-A1 OXAZOLIDINONES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2000-05-18 WO disclosed
WO-2000027816-A1 OXAZOLIDINONES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2000-05-18 WO disclosed
US-5614535-A Adhesion receptor antagonists MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1997-03-25 US disclosed
JP-H0892227-A ADHESION RECEPTOR ANTAGONIST MERCK PATENT GMBH 1996-04-09 JP disclosed
US-5245032-A CATALYTIC PROCESSES FOR THE PREPARATION OF N,N,N-TRISUBSTITUTED NITROGEN-CONTAINING COMPOUNDS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1993-09-14 US disclosed